The product launch marks the fourth launch of Eroxon® in the Nordics since Navamedic introduced the product to the Norwegian market in February 2024. As part of Navamedic’s Consumer Health area, Eroxon® will be available to Danish consumers, without a prescription, across pharmacies.

Ahead of the launch, Navamedic carried out a study through YouGov1[1]. According to the study, more than 500,000 Danish men over the age of 18 have experienced erectile problems, and 23 per cent of Danish men have erectile dysfunction (ED). The study also revealed that four out of ten men who have experienced ED feel it has impacted either their confidence or quality of life.

"These results are not surprising and confirm how widespread erectile problems are. It is still taboo to experience erectile problems, and it has a significant psychological aspect, which we can see with 39 per cent of men where it has affected their self-confidence or quality of life.  We want to change that, and we need to have the courage to talk about men's sexual health," says Fredrik Hultberg, Country Manager at Navamedic.

Including the launch of Eroxon® in Denmark, the product is now available to consumers in Norway, Sweden and Finland. Eroxon® offers a range of features which differentiates it from other forms of treatments for erectile dysfunction. It is an effective and fast-acting gel which typically helps men get an erection within ten minutes of application. It has a good safety profile due to its local effect with no systemic absorption. Eroxon® has been approved as a treatment for erectile dysfunction in the EU and the US.

“We are confident that Eroxon® will be a success in Denmark. Until now, Danish pharmacies have lacked a non-prescription product to treat ED. Based on the recent study, Danish men are looking for a treatment that can quickly provide an erection, and we believe Eroxon® meets that desire as it works within 10 minutes,” added Fredrik Hultberg, Country Manager at Navamedic.

1] About the study

The survey was conducted by the research institute YouGov. A total of 1,526 CAWI interviews were conducted with Danish men and women aged 18-89 years from March 26 to April 1, 2025.